Clovis Oncology Announces Sale of Shares of Common Stock by Selling Stockholders

04-12-2013 Business Wire HealthComments (0)

Clovis OncologyPharmaceutical

Clovis Oncology, Inc. (Nasdaq: CLVS) announced today the pricing of an underwritten public offering of 2,000,000 shares of its common stock at a price to the public of $57.50 per share. All of the shares are being sold by certain existing stockholders who acquired the shares of the Company’s common stock as consideration in connection with the Company’s acquisition of EOS (Ethical Oncology Science) S.p.A. J.P. Morgan Securities LLC is acting as the sole manager

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top